4503 Astellas Pharma
- 1510.0
- -26.0-1.69%
Astellas Pharma News
Astellas Pharma: Confirmation letter
Astellas Pharma: Half Year Report - Term 20 (2024/04/01 - 2025/03/31)
Astellas Pharma: Supplementary financial information for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025
Astellas Pharma: Financial results briefing materials for the 2nd quarter (interim period) of the fiscal year ending March 31, 2025
Astellas Pharma: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [IFRS] (consolidated)
Astellas Pharma: Earnings conference materials for Q1 of the fiscal year ending March 2025.
Astellas Pharma: Supplemental materials for the first quarter financial statements of March 2025.
Astellas Pharma: March 2025 first quarter financial results announcement [IFRS] (consolidated)
Astellas Pharma: Extraordinary Report
Astellas Pharma: Confirmation letter
Astellas Pharma: Securities Report - 19th Period (April 1, 2023 - March 31, 2024)
Astellas Pharma: Financial results briefing materials for the fiscal year ending March 2024
Astellas Pharma: Supplemental Financial Results for the Fiscal Year Ending March 2024
Astellas Pharma: Summary of financial results for the fiscal year ending March 31, 2024 [IFRS] (consolidated)
Astellas Pharma: Revision of full-year earnings forecasts with recorded fair value fluctuations relating to conditional compensation for impairment losses of intangible assets
Astellas Pharma: Confirmation letter
Astellas Pharma: Quarterly Report - 19th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Astellas Pharma: Financial results briefing materials for the 3rd quarter of the fiscal year ending March 31, 2024
Astellas Pharma: Supplemental financial results for the 3rd quarter of the fiscal year ending March 31, 2024
Astellas Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [IFRS] (consolidated)
No Data